Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Molecular determinants of response to high dose androgen therapy in prostate cancer.

Nyquist MD, Corella A, Mohamad O, Coleman I, Kaipainen A, Kuppers DA, Lucas JM, Paddison PJ, Plymate SR, Nelson PS, Mostaghel EA.

JCI Insight. 2019 Sep 10. pii: 129715. doi: 10.1172/jci.insight.129715. [Epub ahead of print]

2.

Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF Signaling.

Bluemn EG, Coleman IM, Lucas JM, Coleman RT, Hernandez-Lopez S, Tharakan R, Bianchi-Frias D, Dumpit RF, Kaipainen A, Corella AN, Yang YC, Nyquist MD, Mostaghel E, Hsieh AC, Zhang X, Corey E, Brown LG, Nguyen HM, Pienta K, Ittmann M, Schweizer M, True LD, Wise D, Rennie PS, Vessella RL, Morrissey C, Nelson PS.

Cancer Cell. 2017 Oct 9;32(4):474-489.e6. doi: 10.1016/j.ccell.2017.09.003.

3.

Exploiting AR-Regulated Drug Transport to Induce Sensitivity to the Survivin Inhibitor YM155.

Nyquist MD, Corella A, Burns J, Coleman I, Gao S, Tharakan R, Riggan L, Cai C, Corey E, Nelson PS, Mostaghel EA.

Mol Cancer Res. 2017 May;15(5):521-531. doi: 10.1158/1541-7786.MCR-16-0315-T.

4.

PIM1 kinase inhibition as a targeted therapy against triple-negative breast tumors with elevated MYC expression.

Horiuchi D, Camarda R, Zhou AY, Yau C, Momcilovic O, Balakrishnan S, Corella AN, Eyob H, Kessenbrock K, Lawson DA, Marsh LA, Anderton BN, Rohrberg J, Kunder R, Bazarov AV, Yaswen P, McManus MT, Rugo HS, Werb Z, Goga A.

Nat Med. 2016 Nov;22(11):1321-1329. doi: 10.1038/nm.4213. Epub 2016 Oct 24.

5.

Direct and indirect targeting of MYC to treat acute myeloid leukemia.

Brondfield S, Umesh S, Corella A, Zuber J, Rappaport AR, Gaillard C, Lowe SW, Goga A, Kogan SC.

Cancer Chemother Pharmacol. 2015 Jul;76(1):35-46. doi: 10.1007/s00280-015-2766-z. Epub 2015 May 9.

6.

Linking tumor mutations to drug responses via a quantitative chemical-genetic interaction map.

Martins MM, Zhou AY, Corella A, Horiuchi D, Yau C, Rakhshandehroo T, Gordan JD, Levin RS, Johnson J, Jascur J, Shales M, Sorrentino A, Cheah J, Clemons PA, Shamji AF, Schreiber SL, Krogan NJ, Shokat KM, McCormick F, Goga A, Bandyopadhyay S.

Cancer Discov. 2015 Feb;5(2):154-67. doi: 10.1158/2159-8290.CD-14-0552. Epub 2014 Dec 12. Erratum in: Cancer Discov. 2018 Aug;8(8):1045. Rakshandehroo, Taha [corrected to Rakhshandehroo, Taha].

7.

Y-chromosome haplotypes defined by 17 STRs included in AmpFlSTR Yfiler PCR Amplification Kit in a multi ethnical population from El Beni Department (North Bolivia).

Tirado M, López-Parra AM, Baeza C, Bert F, Corella A, Pérez-Pérez A, Turbón D, Arroyo-Pardo E.

Leg Med (Tokyo). 2009 Mar;11(2):101-3. doi: 10.1016/j.legalmed.2008.09.002. Epub 2008 Oct 29.

PMID:
18974018
8.

HUMTH01, HUMVWA31A, HUMCSF1PO and HUMTPOX polymorphisms in Amerindian populations living in the Beni department of Bolivia.

Corella A, Bert F, Pérez-Pérez A, Gené M, Turbón D.

Ann Hum Biol. 2008 Sep-Oct;35(5):556-64. doi: 10.1080/03014460802294243.

PMID:
18821332
9.

Mitochondrial DNA diversity of the Amerindian populations living in the Andean Piedmont of Bolivia: Chimane, Moseten, Aymara and Quechua.

Corella A, Bert F, Pérez-Pérez A, Gené M, Turbón D.

Ann Hum Biol. 2007 Jan-Feb;34(1):34-55.

PMID:
17536754
10.

Histoplasmosis associated with exploring a bat-inhabited cave in Costa Rica, 1998-1999.

Lyon GM, Bravo AV, Espino A, Lindsley MD, Gutierrez RE, Rodriguez I, Corella A, Carrillo F, McNeil MM, Warnock DW, Hajjeh RA.

Am J Trop Med Hyg. 2004 Apr;70(4):438-42.

PMID:
15100461
11.

Mitochondrial DNA diversity in the Llanos de Moxos: Moxo, Movima and Yuracare Amerindian populations from Bolivia lowlands.

Bert F, Corella A, Gené M, Pérez-Pérez A, Turbón D.

Ann Hum Biol. 2004 Jan-Feb;31(1):9-28.

PMID:
14742162
12.

Major mitochondrial DNA haplotype heterogeneity in highland and lowland Amerindian populations from Bolivia.

Bert F, Corella A, Gené M, Pérez-Pérez A, Turbón D.

Hum Biol. 2001 Feb;73(1):1-16.

PMID:
11332638
13.

Population study of Aymara Amerindians for the PCR-DNA polymorphisms HUMTH01, HUMVWA31A, D3S1358, D8S1179, D18S51, D19S253, YNZ22 and HLA-DQalpha.

Gené M, Moreno P, Borrego N, Piqué E, Xifró A, Fuentes M, Bert F, Corella A, Pérez-Pérez A, Turbón D, Corbella J, Huguet E.

Int J Legal Med. 2000;113(2):126-8.

PMID:
10741492
14.

Quechua Amerindian population characterized by HLA-DQ alpha, YNZ22, 3'APO B, HUMTH01, and HUMVWA31A polymorphisms.

Gené M, Fuentes M, Huguet E, Piqué E, Bert F, Corella A, Pérez-Pérez A, Corbella J, Moreno P.

J Forensic Sci. 1998 Mar;43(2):403-5.

PMID:
9544552

Supplemental Content

Loading ...
Support Center